Print this page    •   Back to Web version of article

U.S. News
AIDS Healthcare Foundation Challenges Gilead Over AIDS Drug Price Gouging of U.S. Government Programs on Stribild

February 1, 2013

The AIDS Healthcare Foundation (AHF) reported that Gilead Sciences, Inc. charges U.S. HIV patients $28,500 per year for the new HIV drug Stribild, in comparison to $16,600 per patient per year in Canada and European countries with price controls. AHF president Michael Weinstein questioned why Gilead was willing to charge U.S. government programs like ADAP and U.S. HIV patients 42 percent more per patient, per year than price-controlled countries with stronger economies.

When the FDA approved Stribild, a drug that combines four HIV medicines in one pill, in September 2012, Gilead immediately set the U.S. Wholesale Acquisition Cost (WAC) at $28,500. Stribild costs 35 percent more per patient, per year than Atripla, Gilead's best selling three-in-one combination drug.

The WAC for other Gilead drugs also went up in 2013: Atripla increased 6 percent to $1,878.23 per month; Complera went up 5.8 percent to $1,936.53; Emtriva rose by 5.5 percent to $478.45; and Viread increased 6 percent to $771.39.

Weinstein stated AHF challenged Gilead's pricing strategy to educate people in the United States about the cost of HIV medicines and to pressure Gilead into changing its U.S. pricing policies.

Back to other news for February 2013

Excerpted from:
Rock Hill Herald Online (Rock Hill, S.C.)
01.29.2013




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/70441/aids-healthcare-foundation-challenges-gilead-over-.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.